Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy

Epilepsia

Volumn 54, Issue 10, 2013, Pages

  Kim, Dong Wook ^a   Lee, Seo Young ^b   Shon, Young Min ^c   Kim, Ji Hyun ^d  

^a Konkuk University Hospital   (South Korea)

^b Kangwon National University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Korea University College of Medicine   (South Korea)

Author keywords

Apolipoproteins; Atherosclerosis; Cholesterols; Homocysteine; New antiepileptic drugs

Indexed keywords

APOLIPOPROTEIN B; CYANOCOBALAMIN; ETIRACETAM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXCARBAZEPINE; TOPIRAMATE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE MARKER; EPILEPSY; GENERALIZED EPILEPSY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MONOTHERAPY; MULTICENTER STUDY; PRIORITY JOURNAL;

APOLIPOPROTEINS; ATHEROSCLEROSIS; CHOLESTEROLS; HOMOCYSTEINE; NEW ANTIEPILEPTIC DRUGS;

ADULT; ANTICONVULSANTS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CARBAMAZEPINE; CHOLESTEROL, LDL; EPILEPSY; FEMALE; FRUCTOSE; HOMOCYSTEINE; HUMANS; MALE; PIRACETAM; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84885372485     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12338     Document Type: Article

References (12)

1. Belcastro V, Striano P, Gorgone G, Costa C, Ciampa C, Caccamo D, Pisani LR, Oteri G, Marciani MG, Aguglia U, Striano S, Ientile R, Calabresi P, Pisani F,. (2010) Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. Epilepsia 51: 274-279.
2. Cheng LS, Prasad AN, Rieder MJ,. (2010) Relationship between antiepileptic drugs and biological markers affecting long-term cardiovascular function in children and adolescents. Can J Clin Pharmacol 17: e5-e46.
3. Chuang YC, Chuang HY, Lin TK, Chang CC, Lu CH, Chang WN, Chen SD, Tan TY, Huang CR, Chan SH,. (2012) Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia 53: 120-128.
4. Davidson MH,. (2009) Apolipoprotein measurements: is more widespread use clinically indicated? Clin Cardiol 32: 482-486.
5. Ding D, Wang W, Wu J, Ma G, Dai X, Yang B, Wang T, Yuan C, Hong Z, de Boer HM, Prilipko L, Sander JW,. (2006) Premature mortality in people with epilepsy in rural China: a prospective study. Lancet Neurol 5: 823-827.
6. Hamed SA, Hamed EA, Hamdy R, Nabeshima T,. (2007) Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Res 74: 183-192.
7. Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M,. (2008) Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc 83: 1203-1212.
8. Linnebank M, Moskau S, Semmler A, Widman G, Stoffel-Wagner B, Weller M, Elger CE,. (2011) Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann Neurol 69: 352-359.
9. Lopinto-Khoury C, Mintzer S,. (2010) Antiepileptic drugs and markers of vascular risk. Curr Treat Options Neurol 12: 300-308.
10. Mintzer S, Mattson RT,. (2009) Should enzyme-inducing antiepileptic drugs be considered first-line agents? Epilepsia 50 (Suppl. 8): 42-50.
11. Mintzer S, Skidmore CT, Abidin CJ, Morales MC, Chervoneva I, Capuzzi DM, Sperling MR,. (2009) Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein. Ann Neurol 65: 448-456.
12. Morrell MJ, Giudice L, Flynn KL, Seale CG, Paulson AJ, Done S, FLaster E, Ferin M, Sauer MV,. (2002) Predictors of ovulatory failure in women with epilepsy. Ann Neurol 52: 704-711.